Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2017-2021

  • ID: 4397272
  • Report
  • Region: Global
  • 75 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Atomo Diagnostics
  • Bionor
  • F. Hoffmann-La Roche
  • Maccura Biotechnology
  • OraSure Technologies
  • MORE
About Human Immunodeficiency Virus (HIV) Rapid Test Kits

HIV rapid test kits help in determining the presence of antibodies for HIV in body fluids. The test kits include simple, single-use, disposable devices that can provide results within limited time. These devices are designed for using unprocessed specimens such as saliva and blood to detect antibodies. Based on the test, the HIV rapid test kits are of two types, namely, rapid immunoassay test and rapid molecular diagnostic test.

The analysts forecast the global human immunodeficiency virus (HIV) rapid test kits market to grow at a CAGR of 7.23% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global human immunodeficiency virus (HIV) rapid test kits market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • F. Hoffmann-La Roche
  • Alere
Other prominent vendors
  • Abbott
  • AccuBioTech
  • Access Bio
  • Ameritek
  • ALL.DIAG
  • Atomo Diagnostics
  • Autobio Diagnostics
  • Beckman Coulter
  • BD Biosciences
  • Bionor
  • Bio Focus
  • Bio-Rad Laboratories
  • bioMérieux
  • Bundi International Diagnostics
  • Calypte Biomedical
  • CS Innovation
  • Cortez Diagnostics
  • EY Laboratories
  • Hangzhou Biotest Biotech
  • Hema Diagnostics System
  • Hologic
  • JAL Innovation
  • LifeSign
  • Maccura Biotechnology
  • MedMira
  • Medinostics
  • MPI Diagnostics
  • Nectar Lifesciences
  • NTBIO Diagnostics
  • OraSure Technologies
  • PointCare
  • Premier Medical
  • Qiagen
  • Savyon Diagnostics
  • Shanghai Kehua Bioengineering
  • Span Diagnostics
  • Sysmex
  • Trinity Biotech
  • Turklab Tibbi Malzemeler San. Tic.
  • ViennaLab Diagnostics
  • Voxtur Bio
  • Wama Diagnostica
Market drivers
  • Some favorable reimbursements in developed countries
  • For a full, detailed list, view the full report
Market challenges
  • High accuracy of ELISA over HIV rapid test kits
  • For a full, detailed list, view the full report
Market trends
  • Growing preference for self-testing
  • For a full, detailed list, view the full report
Key questions answered in this report:
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Atomo Diagnostics
  • Bionor
  • F. Hoffmann-La Roche
  • Maccura Biotechnology
  • OraSure Technologies
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by end-user
  • Market overview
  • Hospitals and clinics
  • Diagnostic centers
PART 07: Geographical segmentation
  • Market overview
  • HIV rapid test kits market in Americas
  • HIV rapid test kits market in EMEA
  • HIV rapid test kits market in APAC
PART 08: Decision framework

PART 09: Drivers and challenges
  • Market drivers
  • Market challenges
PART 10: Market trends
  • Growing preference for self-testing
  • Increase in testing programs to prove the accuracy of rapid test kits
  • Growth in campaigns to educate people about HIV
PART 11: Vendor landscape
  • Competitive landscape
PART 12: Key vendor analysis
  • Alere
  • F. Hoffmann-La Roche
  • Key companies to watch
  • Other prominent vendors
PART 13: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Benefits associated with HIV rapid test kits
Exhibit 02: Market overview: Global HIV rapid test kits market 2016
Exhibit 03: Market share of global HIV rapid test kits market by technology 2016
Exhibit 04: Global HIV rapid test kits market 2016-2021 ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of global HIV rapid test kits market by end-user 2016
Exhibit 07: Strategical analysis of global HIV rapid test kits market by end-users 2016
Exhibit 08: Buying criteria analysis: Global HIV rapid test kits market 2016
Exhibit 09: Global HIV rapid test kits market by geography in 2016 and 2021 ($ millions)
Exhibit 10: Market overview: HIV rapid test kits market in Americas 2016-2021
Exhibit 11: HIV rapid test kits market in Americas 2016-2021 ($ millions)
Exhibit 12: Market overview: HIV rapid test kits market in EMEA 2016-2021
Exhibit 13: HIV rapid test kits market in EMEA 2016-2021 ($ millions)
Exhibit 14: Market overview: HIV rapid test kits market in APAC 2016-2021
Exhibit 15: HIV rapid test kits market in APAC 2016-2021 ($ millions)
Exhibit 16: Rate of AIDS prevalence globally 2015
Exhibit 17: List of approvals by regulatory bodies for HIV rapid test kits
Exhibit 18: Healthcare common procedure coding systems (HCPCS) for billing
Exhibit 19: Product recalls of HIV rapid test kits
Exhibit 20: Competitive structure analysis of global HIV rapid test kits market 2016
Exhibit 21: Penetration of various global HIV rapid test kits market providers 2016
Exhibit 22: Strategic success factors of companies in global HIV rapid test kits market 2016
Exhibit 23: Alere: Key highlights
Exhibit 24: Alere: Strength assessment
Exhibit 25: Alere: Strategy assessment
Exhibit 26: Alere: Opportunity assessment
Exhibit 27: F. Hoffmann-La Roche: Key highlights
Exhibit 28: F. Hoffmann-La Roche: Strength assessment
Exhibit 29: F. Hoffmann-La Roche: Strategy assessment
Exhibit 30: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 31: bioLytical Laboratories: Company assessment
Exhibit 32: Chembio Diagnostic Systems: Company assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Atomo Diagnostics
  • Bionor
  • F. Hoffmann-La Roche
  • Maccura Biotechnology
  • OraSure Technologies
  • MORE
New Report Released: - Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2017-2021

The author of the report recognizes the following companies as the key players in the global human immunodeficiency virus (HIV) rapid test kits market: F. Hoffmann-La Roche, and Alere.

Other Prominent Vendors in the market are: Abbott, AccuBioTech, Access Bio, Ameritek, ALL.DIAG, Atomo Diagnostics, Autobio Diagnostics, Beckman Coulter, BD Biosciences, Bionor, Bio Focus, Bio-Rad Laboratories, bioMérieux, Bundi International Diagnostics, Calypte Biomedical, CS Innovation, Cortez Diagnostics, EY Laboratories, Hangzhou Biotest Biotech, Hema Diagnostics System, Hologic, JAL Innovation, LifeSign , Maccura Biotechnology, MedMira, Medinostics, MPI Diagnostics, Nectar Lifesciences, NTBIO Diagnostics, OraSure Technologies, PointCare, Premier Medical, Qiagen, Savyon Diagnostics, Shanghai Kehua Bioengineering, Span Diagnostics, Sysmex, Trinity Biotech, Turklab Tibbi Malzemeler San. Tic., ViennaLab Diagnostics, Voxtur Bio, and Wama Diagnostica.

Commenting on the report, an analyst from the research team said: “One trend in the market is growing preference for self-testing. HIV self-testing in home setting only marks the presence of HIV-1/2 antibodies or the HIV-1 p24 antigen, it does not provide diagnosis. The self-testing kit has an inbuilt control line, which makes the performance of the test accurate and reliable. The increasing preference for the self-testing procedure will drive the adoption of the HIV rapid test kits among people.”

According to the report, one driver in the market is some favorable reimbursements in developed countries. The favorable reimbursement scenario is an important contributor to the market growth. The US, Australia, and some countries in the EU are offering limited reimbursement coverage for laboratory testing. For instance, in the US, the Florida Individual Health Insurance Plans Preventive Services Coverage for HIV Testing is offered by both public and private payors, namely Aetna, AvMed, CIGNA, UnitedHealthcare, Humana, and Medicaid, for its citizens. Reimbursements offered by insurance companies to the end-users help in increasing the market adoption and expanding business geographically.

Further, the report states that one challenge in the market is high accuracy of ELISA over HIV rapid test kits. One of the market constraints for the HIV rapid test kits are the false results, which proves the inefficiency of these kits. This has largely impacted the adoption of HIV rapid test kits negatively. According to a NCBI study conducted by the Department of Microbiology, Maulana Azad Medical College, India, revealed that in 2014, the detection of HIV status by using HIV rapid test kits were poor than ELISA. The study was conducted with the help of SD Bioline HIV-1/2 3.0 and Microlisa-HIV, where 787 serum samples were tested for anti-HIV antibodies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • F. Hoffmann-La Roche
  • Alere
  • Abbott
  • AccuBioTech
  • Access Bio
  • Ameritek
  • ALL.DIAG
  • Atomo Diagnostics
  • Autobio Diagnostics
  • Beckman Coulter
  • BD Biosciences
  • Bionor
  • Bio Focus
  • Bio-Rad Laboratories
  • bioMérieux
  • Bundi International Diagnostics
  • Calypte Biomedical
  • CS Innovation
  • Cortez Diagnostics
  • EY Laboratories
  • Hangzhou Biotest Biotech
  • Hema Diagnostics System
  • Hologic
  • JAL Innovation
  • LifeSign
  • Maccura Biotechnology
  • MedMira
  • Medinostics
  • MPI Diagnostics
  • Nectar Lifesciences
  • NTBIO Diagnostics
  • OraSure Technologies
  • PointCare
  • Premier Medical
  • Qiagen
  • Savyon Diagnostics
  • Shanghai Kehua Bioengineering
  • Span Diagnostics
  • Sysmex
  • Trinity Biotech
  • Turklab Tibbi Malzemeler San. Tic.
  • ViennaLab Diagnostics
  • Voxtur Bio
  • Wama Diagnostica
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll